New Stem Cell Therapy To Help With Stubborn Wounds PDF Print E-mail
Friday, 26 August 2011 12:13
The skin is the largest organ in the body with amazing healing powers, but what if your wounds didn't heal?

That's the case for 6 million Americans suffering from chronic wounds that can take months, even years, to heal. Millions have no other choice besides amputation; but now, a new stem cell therapy is helping to change that.

Limited scleroderma or CREST syndrome, is a subtype of Scleroderma, a condition that means "hardened skin." Skin changes associated with CREST syndrome typically occur in the lower arms and legs and sometimes in the face and throat. CREST syndrome can also affect the digestive tract and can cause serious heart and lung disorders. There is no known cure for Scleroderma, but treatments focus on managing symptoms and preventing serious complications. Sometimes, patients with this syndrome have a difficult time healing.

Doctors at the University of Miami Miller School of Medicine are participating in a study that takes stem cells from a patient's own body and uses them to treat their stubborn wounds. Adult stem cells are becoming a more realistic option for treating wounds that are refusing to heal. Certain stem cells can be isolated from bone marrow and other tissues, such as adipose and skin tissue.

Rapid regeneration of skin can be achieved after the transplantation of these cells. Stem cells can be obtained not only from the outside of the skin but also from local skin. Cell therapy is the transplantation of allogeneic cells to restore viability and function of deficient tissues.

Some scholars believe that the plasticity of stem cells is a result of the cell fusion between adult stem cells and skin cells. Therefore, it is important to create an appropriate microenvironment, which will be the determining factor as to whether or not stem cells will survive and participate in regeneration and reparation of wounds.

Researchers are already planning the next trial to test the use of donor bone marrow stem cells on the chronic wounds of patients whose own stem cells are likely compromised.

To learn more about this research, contact head of Media Relations with the University of Miami Miller School of Medicine Omar Montejo at (305) 243-5654 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Source: McFadden, M. (2011), "Healing wounds with your own stem cells", Gray Television Interactive, WNDU.com

 
More articles :

» New Site For Adult Stem Cell Resources Launched

A new website is detailing success stories in adult stem cell research. is part of a campaign to educate and spread awareness about the potentials and successes of adult stem cell therapies, and was created by the Family Research Council and...

» Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies

Jessica Gordon and Robert SpieraReceived 1 June 2011; Revised 2 August 2011; Accepted 2 August 2011Systemic sclerosis (SSc) is a heterogeneous, multisystem disorder characterized by vasculopathy, fibrosis, and autoimmunity in the context of both...

» Biomarker Shows Promise In Scleroderma

A biomarker that can be used to screen patients for has shown promise in a proof of concept study. Researchers from St Vincent’s in Melbourne found (ADMA) levels had an acceptable high specificity and sensitivity for detecting the complication,...

» Mechanism ID’d for Benefit of Stem Cells in Autoimmunity

Bone marrow mesenchymal stem cells (BMMSCs) activate a mechanism involving coupling of FAS/FAS ligand to induce T cell apoptosis and immune tolerance, according to an experimental study published online April 26 in Cell Stem Cell.To investigate the...

» Georgetown Study: Scleroderma Dramatically Under-diagnosed With Commercial Screening Method

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented...

» Targeting Systemic Sclerosis: From Bioinformatics to Clinical Research

Systemic sclerosis (SSc), also known as Scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Dartmouth's Geisel School of Medicine and Northwestern University's Feinberg School of...